We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-0.38%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.39B
AUM Growth
-$121M
Cap. Flow
-$58.4M
Cap. Flow %
-4.19%
Top 10 Hldgs %
6.53%
Holding
988
New
212
Increased
215
Reduced
286
Closed
237

Top Buys

Rank Stock Value
1
LYV icon
Live Nation Entertainment
LYV
+$5.79M
2
SNPS icon
Synopsys
SNPS
+$5.71M
3
NCNO icon
nCino
NCNO
+$5.46M
4
MTD icon
Mettler-Toledo International
MTD
+$5.42M
5
COUR icon
Coursera
COUR
+$5.26M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$11M
2
TTD icon
Trade Desk
TTD
+$5.88M
3
ASAN icon
Asana
ASAN
+$5.8M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$5.66M
5
BA icon
Boeing
BA
+$5.43M

Sector Composition

Rank Sector Weight
1 Healthcare 23.57%
2 Technology 22.7%
3 Consumer Discretionary 13.38%
4 Industrials 12.4%
5 Financials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSC icon
501
SPS Commerce
SPSC
$2.58B
$447K 0.03%
2,771
-2,561
-48% -$316K
LNW
502
DELISTED
Light & Wonder
LNW
$440K 0.03%
+5,300
New +$373K
OI icon
503
O-I Glass
OI
$1.16B
$440K 0.03%
30,808
-3,198
-9% -$47.9K
CYRX icon
504
CryoPort
CYRX
$749M
$439K 0.03%
+6,600
New +$407K
TPTX
505
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$438K 0.03%
+6,591
New +$470K
NGVT icon
506
Ingevity
NGVT
$2.49B
$437K 0.03%
+6,122
New +$483K
STN icon
507
Stantec
STN
$8.1B
$437K 0.03%
9,300
+365
+4% +$17.3K
REVG
508
DELISTED
REV Group
REVG
$436K 0.03%
25,425
-20,622
-45% -$328K
TECH icon
509
Bio-Techne
TECH
$11.2B
$436K 0.03%
+3,600
New +$438K
SYRS
510
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$429K 0.03%
9,608
-2,072
-18% -$101K
CLS icon
511
Celestica
CLS
$36.8B
$427K 0.03%
48,100
-3,965
-8% -$34K
AVA icon
512
Avista
AVA
$3.46B
$420K 0.03%
+10,734
New +$450K
KGC icon
513
Kinross Gold
KGC
$27.2B
$419K 0.03%
78,100
-10,788
-12% -$64.6K
BY icon
514
Byline Bancorp
BY
$1.78B
$418K 0.03%
+17,000
New +$406K
MC icon
515
Moelis & Co
MC
$4.84B
$417K 0.03%
+6,733
New +$403K
AZO icon
516
AutoZone
AZO
$51.4B
$416K 0.03%
245
NVAX icon
517
Novavax
NVAX
$1.19B
$415K 0.03%
+2,000
New +$441K
MTH icon
518
Meritage Homes
MTH
$4.8B
$409K 0.03%
+8,436
New +$434K
TECX
519
Tectonic Therapeutic
TECX
$529M
$407K 0.03%
6,085
+1,385
+29% +$114K
CVLT icon
520
Commault Systems
CVLT
$5.01B
$402K 0.03%
+5,343
New +$414K
MERC icon
521
Mercer International
MERC
$42.9M
$398K 0.03%
34,300
-7,235
-17% -$83.9K
NOTV
522
DELISTED
Inotiv
NOTV
$398K 0.03%
13,600
-2,435
-15% -$70.9K
PAHC icon
523
Phibro Animal Health
PAHC
$1.48B
$398K 0.03%
+18,479
New +$445K
MCB icon
524
Metropolitan Bank Holding Corp
MCB
$1.15B
$396K 0.03%
+4,700
New +$342K
SNDR icon
525
Schneider National
SNDR
$6.1B
$396K 0.03%
+17,422
New +$385K

Similar funds

PDT Partners's Q3 2021 Portfolio in Review

As of Q3 2021, PDT Partners held 988 positions worth $1.39B, down 8% from $1.51B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

PDT Partners withdrew a net $58.4M in Q3 2021, closing 237 positions and reducing 286 holdings. Its most notable exit was Stellantis, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Live Nation Entertainment worth $6.26M.

  • PDT Partners's largest Q3 2021 buy was Live Nation Entertainment: 68,700 shares worth $6.26M.
  • PDT Partners added most to Mettler-Toledo International in Q3 2021, an estimated $5.42M increase.
  • PDT Partners's biggest Q3 2021 reduction was Asana, cutting an estimated $5.8M.
  • PDT Partners fully exited Stellantis in Q3 2021, selling an estimated $11M.
  • PDT Partners's ten largest holdings make up 6.5% of its $1.39B portfolio in Q3 2021.
  • PDT Partners opened 212 new positions and closed 237 in Q3 2021.
  • PDT Partners's portfolio value fell 8% quarter-over-quarter to $1.39B.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.